On Nov 18, 2021 Cardiff Oncology closed a Post-IPO Equity round and raised $15,000,000 from Pfizer Breakthrough Growth Initiative, featuring lead investors Pfizer Breakthrough Growth Initiative.

About the company: Cardiff Oncology is located at United States, North America.
“Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.”

Company website: http://www.cardiffoncology.com